Associations Between Findings From Myelin Water Imaging and Cognitive Performance Among Individuals With Multiple Sclerosis

Abstract

Multiple sclerosis (MS) is an inflammatory, neurodegenerative disease of the central nervous system¹ that affects more than 2 million people globally, rendering it the most prevalent chronic neuroinflammatory disease of the central nervous system worldwide.² Cognitive impairment is a common symptom in MS that presents in up to 70% of patients.³ Cognitive symptoms in MS typically manifest as deficits in attention, memory, and processing speed,³ with processing speed being most frequently affected.⁴